- Home
- STFS vs CCEL Comparison
STFS vs CCEL Comparison
Compare STFS & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STFS
- CCEL
- Stock Information
- Founded
- STFS 2015
- CCEL 1989
- Country
- STFS China
- CCEL United States
- Employees
- STFS N/A
- CCEL N/A
- Industry
- STFS
- CCEL Managed Health Care
- Sector
- STFS
- CCEL Health Care
- Exchange
- STFS NYSE
- CCEL Nasdaq
- Market Cap
- STFS 49.0M
- CCEL 50.0M
- IPO Year
- STFS 2024
- CCEL 1997
- Fundamental
- Price
- STFS $4.47
- CCEL $8.43
- Analyst Decision
- STFS
- CCEL
- Analyst Count
- STFS 0
- CCEL 0
- Target Price
- STFS N/A
- CCEL N/A
- AVG Volume (30 Days)
- STFS 326.5K
- CCEL 39.4K
- Earning Date
- STFS 11-26-2024
- CCEL 11-26-2024
- Dividend Yield
- STFS N/A
- CCEL 2.97%
- EPS Growth
- STFS 43.59
- CCEL N/A
- EPS
- STFS 0.15
- CCEL N/A
- Revenue
- STFS $14,972,726.00
- CCEL $31,838,476.00
- Revenue This Year
- STFS N/A
- CCEL $3.97
- Revenue Next Year
- STFS N/A
- CCEL $0.91
- P/E Ratio
- STFS $29.00
- CCEL N/A
- Revenue Growth
- STFS 57.60
- CCEL 1.95
- 52 Week Low
- STFS $2.82
- CCEL $3.67
- 52 Week High
- STFS $4.60
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- STFS N/A
- CCEL 62.23
- Support Level
- STFS N/A
- CCEL $7.00
- Resistance Level
- STFS N/A
- CCEL $9.43
- Average True Range (ATR)
- STFS 0.00
- CCEL 0.74
- MACD
- STFS 0.00
- CCEL 0.15
- Stochastic Oscillator
- STFS 0.00
- CCEL 72.45
About STFS STAR FASHION CULTURE HOLDINGS LIMITED
Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. It offer services focusing on (i) marketing campaign planning and execution; (ii) offline advertising services; and (iii) online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.